B O O K - American College of Rheumatology

impact 1063, 1325
inactive disease 2220
INCB028050 2172
inception cohort 2273
incidence 112, 568
incidence rate 972
inclusion body myositis 922
index 1878
indigenous peoples 1538
indomethacin 151
indoor falls 684
inducible NO synthase (iNOS) 1489
inefficacy 1110
infection 237, 248, 313, 316, 335, 341, 342,
346, 400, 403, 414, 421, 698, 758, 782, 1381,
1390, 1638, 1640, 1642, 1643, 1648, 1649,
1669, 1678, 1876, 1969, 2023, 2103, 2216
inflammasome 265, 2228
inflammation 86, 88, 106, 134, 145, 151, 260,
270, 288, 360, 369, 441, 443, 499, 536, 675,
679, 714, 844, 854, 855, 864, 866, 949, 1034,
1041, 1081, 1109, 1130, 1239, 1270, 1296,
1309, 1422, 1424, 1426, 1470, 1506, 1509,
1512, 1524, 1525, 1533, 1607, 1622, 1707,
1728, 1761, 1785, 1813, 1883, 1953, 2044,
2078, 2109, 2150, 2162, 2200, 2204, 2229,
2231, 2233, 2260
inflammatory arthritis 19, 28, 300, 629, 659,
712, 716, 766, 778, 794, 890, 901, 904, 978,
997, 1029, 1067, 1391, 1418, 1427, 1665, 1710,
1729, 1737, 2227
inflammatory back pain 544
inflammatory bowel disease (IBD) 223, 537,
901
inflammatory diseases 2217
inflammatory markers 385
infliximab 216, 234, 328, 352, 381, 420, 988,
1276, 1300, 1436, 1542, 1680, 1743, 1826,
1829, 1945, 1960, 2265
influenza 224, 237, 478, 1238
influenza vaccine 1694
information needs 1408
information technology 221, 2111, 2284
infusion therapy 1002
inhibitor 1358
inhibitory kappaB 1487
injection 947, 1567, 1626, 2225
innate immune cells 866
innate immunity 845, 935, 1883, 2230
innate lymphocyte 2232
in-patient 1576
insole 2134
instrument validation 1337
insulin receptor 1514
insulin resistance 389
insulin-like growth factor 670, 1501
integrins 844, 865, 1719
intensive care unit 2102
inter- and intra-observer agreement 1623
inter- and intra-rater variability 1623
inter-disciplinary consensus 1212
interferon regulatory factor 433, 1712
interferon signature 1904
interferon-γ assay 756
interferon-gamma release assay 782
interferon-regulatory factor-4 435
interferons 271, 428, 433, 493, 494, 496, 501,
503, 850, 868, 934, 1164, 1181, 1183, 1199,
1376, 1660, 1661, 1712, 1904, 2187, 2188,
2189, 2278
interfreon-alpha 1181
interleukin (IL) -32 277
interleukin 1 1831
interleukin 1 receptor antagonist 271
interleukin 6 1247
interleukin-1 272
interleukin-1 receptor associated kinase-1 1587
interleukin-13 675
interleukin-17 1271
interleukin-18 703
interleukin-1b (IL-1)- 1489
interleukin-23 1271
interleukin-6 30, 272, 1096, 2168
interleukin-7 278
interleukins (IL) 18, 19, 29, 35, 152, 153, 260,
265, 271, 276, 278, 282, 353, 358, 369, 371,
373, 432, 629, 637, 657, 707, 831, 895, 903,
1088, 1121, 1124, 1126, 1241, 1260, 1270,
1308, 1412, 1435, 1488, 1531, 1607, 1664,
1831, 1903, 1970, 2158, 2203
interlleukin-2 receptor alpha (sIL-2Ra) 49
intermittent and constant osteoarthritis pain
(ICOAP) 682
international 969, 1013
internet 1340, 1362
internet survey 807
internet use 1409
interprofessional practice 2050
inter-rater discrimination 1652
interstitial keratitis 1675
interstitial lung disease 592, 602, 919, 932,
1035, 1044, 1086, 1377, 1672, 1803, 1824
interstitial pneumonia 1042
intestinal Behcet’s disease 1300
intestinal involvement 1297
intestinal microbiota 1390
intestinal parasitosis 539
intima media thickness 455
intimal hyperplasia 1294
intima-media thickness 1028
intra articular 943, 947, 2225
intracellular signalling 1357
intracranial hemorrhage 2037
intravenous immunoglobulin (IVIG) 494, 576
invasion 1387, 1421
ion channels 1270
iontophoresis 218
IRF-1 282
IRF5 1607
iridocyclitis 528
IR-induced DNA damage 509
ITGAM 637
J
JAK1/JAK2 2172
janus kinase (JAK) 269, 717, 1137, 1240, 2171,
2172, 2233
janus kinase 2 (JAK2) inhibition 2233
janus-kinase-1 2200
Japanese 237, 399, 1285, 1577, 1672
JNK 32
job 2139
job loss 80, 781, 1541, 1548, 2079
joint count 166, 723, 1759
joint damage 2109
joint destruction 32, 73, 132, 272, 367, 536,
716, 887, 1470, 1479, 1482, 1495, 1600, 1610,
1738, 1747, 1785, 1812, 1821, 1828, 2256,
2258, 2273
joint distraction 176, 1380
joint examination 1781
joint procedures 1539
joint space distance 136
joint space narrowing 132, 707, 1369
joint swelling 79, 2258
junctional adhesion molecule 1419
juvenile arthritis 207, 220, 224, 251, 259, 1407,
2219
juvenile dermatomyositis 242, 252, 928, 1344,
1672, 1678, 1700
juvenile fibromyalgia 807
juvenile idiopathic arthritis (JIA) 206, 208, 209,
210, 213, 214, 216, 217, 218, 219, 222, 224,
226, 227, 228, 229, 230, 231, 232, 235, 236,
237, 238, 239, 243, 244, 245, 247, 248, 250,
253, 254, 255, 256, 258, 263, 264, 654, 655,
1012, 1339, 1404, 1405, 1406, 1408, 1434,
1491, 1601, 1630, 2084, 2103, 2219, 2220, 2248
juvenile idiopathic arthritis-enthesitis (ERA)
219, 233, 235, 266
juvenile localized scleroderma of the face 1687
juvenile myositis 1379, 1678
juvenile onset patients 1697
juvenile polyarteritis nodosa 2033
juvenile psoriatic arthritis 219
juvenile scleroderma 1439, 1682, 1687, 1704
juvenile sclerosis 1704
juvenile spondylarthropathy 212, 225, 266,
1633
abstract KEYWORD INDEX
2010 Program Book 365